期刊文献+

联合用药缩小凡纳滨对虾斑点气单胞菌耐药突变选择窗的研究 被引量:2

Narrowing mutant selection window of Aeromonas punctata from Litopenaeus vannamei by combination of antibiotics
下载PDF
导出
摘要 通过测定斑点气单胞菌单药和双药抗生素最低抑菌浓度(MIC)、防突变浓度(MPC)和耐药突变选择窗(MSW),探索合理使用抗菌药物,防止细菌耐药性产生的用药方案。利用药物敏感性实验测定斑点气单胞菌对10种抗生素的抗性,筛选出6种不同机制的敏感性抗菌药物,应用琼脂平板稀释法对斑点气单胞菌测定单药以及双药的最低抑菌浓度(MIC)和防突变浓度(MPC),计算选择指数(SI)和联合指数(CI),测定联合用药对耐药突变选择窗(MSW)的影响。结果显示:6种药物氯霉素、土霉素、利福平、红霉素、盐酸四环素、头孢霉素的MIC分别为0.512、0.416、6.272、2.048、0.386和0.512μg/m L;MPC分别为524.288、1 277.952、802.816、1 024.000、1 185.792和10.880μg/m L;SI值分别为1 024.000、3 072.000、128.000、500.000、3 072.000和21.250。土霉素与红霉素、盐酸四环素与红霉素、盐酸四环素与头孢霉素、土霉素与头孢霉素、盐酸四环素与土霉素、氯霉素与土霉素、氯霉素与盐酸四环素、利福平与氯霉素、利福平与头孢霉素、利福平与盐酸四环素、利福平与土霉素、红霉素与头孢霉素双药联合后的联合指数分别为1.000、1.000、1.000、1.000、0.834、1.500、1.500、0.834、2.000、2.000、1.000和2.000。双药联合明显降低了药物SI值,有效缩小了斑点气单胞菌耐药突变选择窗,其中利福平与盐酸四环素双药联合后SI值由128.000,3 072.000均降低至1.000,完全关闭了耐药突变选择窗,有效抑制斑点气单胞菌的耐药生长。 The purpose of this study is to explore the rational use of antimicrobial drugs, and prevent bacterial resistance to antibiotics through determination minimal inhibitory concentration (MIC), mutant prevention concentration(MPC) and mutant selection window (MSW) of monotherapy and double medicine antibiotics on Aeromonas punctata. Resistances of 10 antibiotics were tested via drugs sensitivity assays, 6 sensitive antimicrobial drugs with different mechanisms were screened and their MIC, MPC, selection index (SI) and MSW to Aeromonas punctata were determined respectively via single-drug and double-drug' s combination by agar plate dilution method. The MIC of chloramphenicol, oxytetracycline, rifampicin, erythromycin, tetracycline hydrochloride, cephalosporins were 0. 512,0.416,6. 272,2. 048,0. 386,0.512 ixg/mL, respectively. The MPC of 6 antibiotics were 524. 288,1 277. 952,802.816,1 024. 000,1 185. 792, 10. 880 ixg/mL. The SI were 1 024. 000, 3 072. 000, 128. 000,500. 000, 3 072. 000, 21. 250. The combination index of oxytetracycline and erythromycin, tetracycline hydrochloride and erythromycin, tetracycline hydrochloride and cephalosporins, oxytetracycline and cephalosporins, tetracycline hydrochloride and oxytetracycline, chloramphenicol and oxytetracycline, chloramphenicol and tetracycline hydrochloride, rifampicin and chloramphenicol, rifampicin and cephalosporins, rifampicin and tetracycline hydrochloride, rifampicin and oxytetracycline, erythromycin and cephalosporins were 1. 000,1. 000,1. 000,1. 000,0. 834, 1. 500,1. 500,0. 834,2. 000,2. 000,1. 000,2. 000, respectively. It was confirmed that the mutant selection window of A. punctata was narrowed effectively via double drug combination. The Sis declined from 128. 000 and 3 072. 000 to 1. 000 and 1. 000 after combination of rifampicin and tetracycline, so this demonstrated that combination of rifampicin and tetracycline closed the resistant mutant selection window, and inhibited effectively the resistant growth of A. punctata.
出处 《水产学报》 CAS CSCD 北大核心 2015年第4期566-572,共7页 Journal of Fisheries of China
基金 国家自然科学基金(30871648) 广东省教育部产学研专项(2011B090400416) 中山市科技计划专项(20123A317) 电子科技大学中山学院科研团队培育专项(412YT02)
关键词 斑点气单胞菌 凡纳滨对虾 联合用药 最低抑菌浓度 防突变浓度 耐药突变选择窗 Aeromonas punctata Litopenaeus vannamei, combinated antibiotics MIC MPC MSW
  • 相关文献

参考文献19

  • 1Altwegg M, Martinetti L G, Luthy H Aeromonas-associated gastroenteritis consumption of contaminated shrimp [ J ] Journal of Clinical Microbiology and Diseases, 1991,10 ( 1 ) :44 - 45. 被引量:1
  • 2J, et al. after European Infectious Firsov A A, Vostrov S N ,Lubenko I Y, et al, In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus [ J ]. Antimicrobioal Agents Chemotherapy, 2003,47 ( 5 ) : 1604 - 1613. 被引量:1
  • 3Cui J,Liu Y, Wang R, et al. The mutant selection window in rabbits infected with Staphylococcus aureus[ J]. Journal of Infectious Diseases, 2006,194 (11) :1601 - 1608. 被引量:1
  • 4俞观泉,卢彤岩,杨雨辉.几种抗菌药物对嗜水气单胞菌突变选择窗(MSW)范围的研究[J].中国兽医杂志,2012,48(12):73-75. 被引量:4
  • 5王浩,权可艳,徐丽娟,李梦影,吕利群.恩诺沙星控制草鱼维氏气单胞菌的用药方案[J].淡水渔业,2013,43(2):48-53. 被引量:13
  • 6Clinical and Laboratory Standards Institute/NCCLS. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement [ J ]. Clinical and Laboratory Standards Institute Document,2010,30( 1 ) : 1. 被引量:1
  • 7Kluytmnas J, van Belkum A, Vehturhg H. Nasal carriage of Staphylococcus aureus. Epidemiology, underlying mechanisms, and associated risks [ J ]. Clinical Microbiology Reviews, 1997, 10 (3): 505 - 520. 被引量:1
  • 8Lucet J C, Chevret S, Durand Z L, et al. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit,results of a multicenter study [ J ]. Archives OF Internal Medicine ,2003,163 ( 2 ) : 181 - 188. 被引量:1
  • 9Cesur S, Ckoca F. Nasal carriage of methicillin- resistant Staphylococcus aureus among hospital staff and outpatinets [ J ]. Infection Control and Hospital Epidemiology, 2004,25 ( 2 ) : 169 - 171. 被引量:1
  • 10赵占春.气单胞菌属(Aeromonas)的新分类法及临床鉴定,哈尔滨医药,1982,2(2):100-102. 被引量:1

二级参考文献133

共引文献144

同被引文献30

  • 1崔俊昌,刘又宁,王睿,童卫杭,梁蓓蓓.左氧氟沙星药代动力学/药效动力学参数与金黄色葡萄球菌耐药的相关性研究[J].中国临床药理学与治疗学,2007,12(9):989-992. 被引量:25
  • 2CREDITO K, K0S0WSKA - SHICK K, APPELBAUM P C. Mu-tant prevention concentrations of four carbapenems against gram -negative rods [ J]. Antimicrob Agents Chemother, 2010,54 (6):2692 -2695. 被引量:1
  • 3DONG Y,ZHAO X’ DOMAGALA J, et al. Effect of fluoroquinolo-ne concentration on selection of resistant mutants of Mycobacteriumbovis BCG and Staphylococcus aureus [ J]. Antimicrob Agents Che-mother, 1999t43(7):1756 -1758. 被引量:1
  • 4ZHAO X, DRLICA K. Restricting the selection of antibiotic - re-sistant mutant bacteria : measurement and potential use of the mutantselection window [J]. J Infect Dis,2002,185(4) :561 -565. 被引量:1
  • 5FIRSOV A A,VOSTROV S N, LUBENKO I Y, et al. In vitropharmacodynamic evaluation of the mutant selection window hypo-thesis using four fluoroquinolones against Staphylococcus aureus[J]. Antimicrob Agents Chemother, 2003 ,47(5) :1604 -1613. 被引量:1
  • 6CROISIER D,ETIENNE M, CHARLES P, et al. In vivo phannaco-dynamic efficacy of gatiiloxacin a^inst Streptococcus pneumoniae inan experimental model of pneumonia: impact of the low levels offluoroquinolone resistance on the enrichment of resistant mutants[J ]. J Antimicrob Chemother,2004 ’54(3) :640 - 647. 被引量:1
  • 7LIU Y,CUI J,WANG R,et al. Selection of rifampicin resistantStaphylococcus aureus during tuberculosis therapy : concurrent bacte-rial eradication and acquisition of resistance [ J]. J Antimicrob Che-mother, 2005,56(6):1172-1175. 被引量:1
  • 8ZHAO X,DRLICA K. Restricting the selection of antibiotic - re-sistant mutants : a general strategy derived from fluoroquinolonestudies [ J ]. 2001 - 09 - 15 [ 2015 - 11 -25]. http://www. nc-bi. nlm. nih. gov/pubmed/? term. 被引量:1
  • 9CAI Y, YANG J, KAN Q, et al. Mutant prevention concentrationof colistin alone and in combination with levofloxacin or tobramycinagainst multidrug - resistant Acinetobacter baumannii [ J] . Int J An-timicrob Agents, 2012, 40(5) :477 -478. 被引量:1
  • 10王睿.药代动力学/药效学理论在呼吸道感染治疗中的应用[J].中国实用内科杂志,2009,29(9):865-867. 被引量:8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部